Cellular and Molecular Biology

Free Version

Upgrade subject to access all content


Receptor Tyrosine Kinases as Therapeutic Targets


Receptor Tyrosine Kinases (RTKs) are necessary for numerous cell-signaling events which promote cell growth and replication. RTK-1 activation leads to signaling through Ras/Rap/MAPK pathway.

A rare mutation resulting in a constitutively active form of RTK-1 causes a rare form of leukemia. Using a drug which binds close to an ATP binding pocket prevents tumor growth.

How might this drug alter RTK-1 activity?


The drug increases RTK-1 activity by facilitating the transfer of phosphate to a serine residue on RTK-1.


The drug decreases RTK-1 activity by inhibiting the binding of ATP in its proper binding pocket.


The drug increases RTK-1 activity by facilitating autophosphorylation, a common method of tyrosine kinase receptor activation.


The drug transiently increases RTK-1 activity followed by a continued decrease of activity by facilitating receptor desensitization.